headquart san diego california
pure play diabet compani focus continu
reason report
price chang estim chang analysi
reiter o/v invest rate share
increas former price target per
seen past year market adopt cgm
remain strong evolv channel dynam favor pharmaci
benefit model stand increas patient access cgm
increas price increas former
materi perform subsequ
revenu guidanc increas increas former
revenu earn estim million
million per share respect import
corpor guidanc annual loss estim
summari thought valuat share current
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
headwind channel shift price competit weight heavili addit annual gross
non recur expens associ faster forecast transit inventori
dollar thousand except per share data
fiscal period
fiscal period
revenu
research develop
sell gener administr
research develop
sell gener administr
research develop
compani report stephen inc estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
